Skip to main content
. 2024 Oct 15;11:1427982. doi: 10.3389/fmed.2024.1427982

Figure 5.

Figure 5

(A) Positive cytoplasmic HMB-45 immunoexpression (IHC, magnification 200x), (B) positive cytoplasmic Melan-A immunoexpression (IHC, magnification 200x), (C) positive cytoplasmic s-100 immunoexpression (IHC, magnification 200x), (D) positive cytoplasmic Vimentin immunoexpression (IHC, magnification 200x), (E) positive nuclear SOX-10 immunoexpression (IHC, magnification 200x), and (F) positive nuclear Ki-67 immunoexpression (<5%) (IHC, magnification 200x).